Ubie

Ubie Competitive Intelligence & Landscape

ubiehealth.com ·

Ubie
ForesightIQ Predictions

What is Ubie likely to do next?

ForesightIQ connects Ubie's hiring, product, web, ad, and market signals to forecast strategic moves — often months before they're announced.

Hiring signal

Senior hiring patterns point to a planned enterprise product line launching within two quarters.

High confidence · Next 1–2 quarters
Product signal

Quiet changes to docs and pricing pages signal an upcoming usage-based pricing tier and new API surface.

Likely · Next quarter
Market signal

Ad spend and partnership activity indicate a push into the mid-market segment across two new regions.

Plausible · Next 2–3 quarters
Ubie Unlock Ubie's predicted moves

Free · generated in ~60 seconds · no signup to preview

Overview

Ubie Overview

Ubie (ubiehealth.com) is a pioneering healthcare AI startup that bridges the gap between patients and healthcare systems. Founded in Japan by an MD and an engineer, the company operates globally with a mission to make healthcare more accessible [https://business.ubiehealth.com/].

Ubie has established a strong presence in the United States, launching its AI-powered symptom checker in 2022 and establishing a subsidiary in New York [https://ubiehealth.com/company/newsroom/ubie-launches-ai-powered-symptom-checker-in-the-us], [https://ubiehealth.com/company/newsroom/ubie-closes-extended-series-c-round-at-45-million]. The company has garnered recognition, being nominated by LinkedIn as the fastest-growing startup in Japan in 2021 [https://recruit.ubiehealth.com/].

The core offering of Ubie is its AI Symptom Checker, a free and user-friendly tool available on ubiehealth.com [https://ubiehealth.com/]. This system allows individuals to check their symptoms and find possible causes within approximately three minutes. The questionnaire is customized based on personal information such as biological sex, age, and medical history to provide relevant suggestions [https://ubiehealth.com/]. After completing the assessment, users receive a detailed report outlining potential causes, treatment information, and guidance on when to seek professional medical attention [https://ubiehealth.com/]. The company also offers specialized tools for healthcare providers [https://ubiehealth.com/company/for-hcps].

Ubie's target market includes both individual consumers seeking to understand their symptoms and healthcare systems globally. Its enterprise platforms are trusted by over 1,900 health systems, demonstrating its reach and impact within the medical community [https://business.ubiehealth.com/]. The company emphasizes its commitment to medically validated AI, ensuring the accuracy and reliability of its tools [https://business.ubiehealth.com/].

Ubie is an agile organization known for its frequent releases and user-centric approach, applying Holacracy and being backed by IDEO [https://recruit.ubiehealth.com/].

Competitors

Ubie Competitors

Ubie (ubiehealth.com) is an AI-powered health assistant that offers a free symptom checker to help users understand potential causes for their symptoms and guide them to appropriate medical care. The system generates a personalized report after a three-minute questionnaire, taking into account biological sex, age, and medical history.

Ubie has been recognized as a leader among its peers, demonstrating a strong focus on accuracy in its AI-based symptom checking, with a Top-10 hit accuracy of 71.6%.

Among Ubie's direct competitors is Infermedica, a health technology company also specializing in AI-powered tools for the healthcare sector. Like Ubie, Infermedica provides a symptom checker and virtual triage system aimed at assisting patients in understanding their health concerns. While both companies leverage AI for symptom assessment, Ubie emphasizes its free, user-friendly questionnaire and personalized reports, making it accessible for initial self-assessment.

Doctronic is another notable competitor in the digital healthcare space. This company also utilizes AI to deliver medical consultations and health information. Similar to Ubie, Doctronic aims to provide guidance and insights into health conditions. However, specific details on Doctronic's pricing model or direct feature comparisons to Ubie's free symptom checker and report generation are not readily available, making their differentiation less clear in terms of direct user accessibility and cost.

Indirect competitors to Ubie include broader digital health platforms and telemedicine providers like K Health and Healthline. While K Health offers AI-driven health services that can include symptom assessment, it often integrates with virtual doctor visits, representing a more comprehensive and potentially paid healthcare solution beyond just a symptom checker.

Healthline, on the other hand, is primarily a vast medical information resource, offering articles and guides rather than an interactive AI symptom assessment tool like Ubie.

Other companies like Zocdoc and Talkspace also operate in the digital health ecosystem but serve different primary functions.

Zocdoc focuses on helping patients find and book doctor's appointments, and Talkspace specializes in online therapy and psychiatry. These services are complementary to Ubie's initial symptom checking but do not directly compete in the AI-powered symptom assessment market where Ubie provides its free, initial diagnostic guidance.

Alternatives

Ubie Alternatives

Product & Pricing

Ubie Product and Pricing Intelligence

Ubie (ubiehealth.com) offers distinct products targeting both individual consumers and healthcare providers, with varying pricing models. For individuals, Ubie provides a free AI-powered symptom checker, allowing users to assess potential causes for their symptoms in just three minutes. This complimentary service generates a personalized report including possible causes, treatment information, and guidance on when to see a doctor. The symptom checker is free to use, requiring no credit card or sign-up pressure, and personalizes questions based on biological sex, age, and medical history.

For healthcare organizations, Ubie offers Ubie Smart Support, an AI-powered patient support platform. This professional-grade solution is co-developed with Mayo Clinic and automates clinical intake, patient routing, and appointment scheduling 24/7 across voice and chat.

Ubie Smart Support unifies first-contact resolution, self-scheduling, and clinical triage, aiming to replace fragmented systems like IVRs and schedulers.

While the individual symptom checker is free, pricing for Ubie Smart Support for healthcare providers is not explicitly detailed on the website. Instead, interested organizations are prompted to "Book a Demo" or "Download info," indicating a customized pricing model likely based on the scale and specific needs of the healthcare facility. There are no recent public announcements regarding changes to the pricing structure for either the free individual symptom checker or the enterprise Smart Support platform.

Hiring & Layoffs

Ubie Hiring and Layoffs

Ubie (ubiehealth.com) maintains a dynamic global team, with a strong presence in Japan, the APAC region, and the United States. As of a recent overview, Ubie employs approximately 240 individuals at its Tokyo headquarters, 10 in its APAC headquarters, and 4 in its U.S. headquarters. This structure reflects the company's commitment to global expansion and its mission to develop a healthcare guide for everyone, leveraging AI-powered solutions to improve patient access and streamline healthcare for providers.

While Ubie is actively growing its global presence, its recruitment website indicates that full-time roles are currently filled, advising interested candidates to monitor Ubie's LinkedIn for the latest job openings. The company's hiring process emphasizes

Leadership

Ubie Management and Leadership Team

Ubie (ubiehealth.com) was co-founded in May 2017 by Dr. Yoshinori Abe and Kota Kubo. Dr. Abe, a physician who graduated from The University of Tokyo School of Medicine, currently serves as Ubie's CEO and Product Owner [ubiehealth.com/doctors/yoshinori-abe]. Kota Kubo, a software engineer with a Master of Engineering from The University of Tokyo, also played a pivotal role in the company's inception [recruit.ubiehealth.com/overview-1], with Ubie's origin story emphasizing their combined medical and technological expertise [ubiehealth.com/company/origin].

The leadership team extends beyond its founders, with Ubie emphasizing a collaborative approach to medical AI development. The platform is developed and supervised by a diverse team of over 50 doctors from around the world [ubiehealth.com/doctors]. This global network of medical experts ensures that the AI symptom checker is continuously improved and rigorously reviewed [ubiehealth.com].

Notable medical professionals involved in the development and supervision of Ubie's content include Unnati Patel, MD, MSc, a Family Medicine physician and Center Medical Director at Oak Street Health in Arizona [ubiehealth.com/diseases/essential-hyperlipidemia], and Eric A. Gantwerker, MD, MMSC, associated with Northwell Health [ubiehealth.com/doctors]. Other supervising doctors include Ami Shah Vira, MD, Jerry Tee Todd, MD, Maxwell J. Nanes, DO, Caroline M. Doan, DO, and Charles Carlson, DO, MS [ubiehealth.com]. This extensive medical oversight underscores Ubie's commitment to clinical accuracy and user safety, with their Privacy Policy also referencing a dedicated Data Protection/Grievance Officer [ubiehealth.com/privacy-policy].

Financials

Ubie Financial Performance, Fundraising, M&A

Ubie (ubiehealth.com), a leading healthcare AI startup originating from Japan, has demonstrated robust financial growth and fundraising activity to fuel its global expansion. The company successfully closed an extended Series C funding round, raising $45 million, adding to a previous Series C round of $26.2 million. This brings their total funding to an impressive cumulative sum of over $125 million, with Ubie being backed by notable investors, including Google and IDEO's partner Design for Ventures. These significant funding rounds underscore investor confidence in Ubie's innovative AI-powered healthcare solutions and its strategic vision.

Since its inception in May 2017, Ubie has established a strong financial foundation, reflected in its cumulative funding total. While specific revenue figures are not publicly disclosed, the substantial capital raised has enabled Ubie to expand its operations globally, with offices in Tokyo, Singapore, and New York. This financial backing supports their mission to develop a comprehensive healthcare guide for everyone, utilizing their clinical-grade AI platform that has already been adopted by over 1,800 healthcare organizations in Japan.

Ubie's financial health and growth trajectory are further evidenced by its status as one of Japan's fastest-growing startups, as recognized by LinkedIn in 2021. The continuous influx of capital supports Ubie's ambitious US expansion, particularly targeting generative AI and provider solutions. While no explicit M&A activities are publicly detailed, the significant investment in its core AI technology and global outreach suggests a focus on organic growth and strategic partnerships within the healthcare ecosystem to enhance its service offerings and market presence.

Partnerships

Ubie Partnerships, Clients and Vendors

Ubie (ubiehealth.com) cultivates a robust network of partnerships and integrations to enhance its AI-powered healthcare solutions. A significant collaboration is with the Mayo Clinic, with whom Ubie co-developed its Smart Support system. This platform, validated by the Mayo Clinic and backed by Google, automates clinical intake, patient routing, and scheduling, aiming to streamline healthcare operations for providers by unifying various first-contact resolution functionalities into a single AI layer [ubiehealth.com/smart-support][business.ubiehealth.com/smart-support].

Ubie Smart Support boasts extensive integration capabilities, including bidirectional scheduling API support for EPIC, and compatibility with Oracle Health and Athena systems. This allows for rapid implementation, with systems going live in as little as 90 days, avoiding lengthy and disruptive rip-and-replace processes [business.ubiehealth.com/smart-support]. The company also works with numerous individual medical clinics and practices, such as C T Yeo Respiratory & Medical Clinic, Daniel Wai Diabetes, Thyroid and Hormone Clinic Pte. Ltd., P Tan Family Medicine Clinic, SOMERSET GP PTE LTD, TRINITY COMPREHENSIVE HEALTHCARE CENTER, R Zakaria Physician PLLC, Dr. David Hurwitz's Pediatric Office, and Hibiscus Health & Wellness [ubiehealth.com/pcv-partners].

Ubie's AI Symptom Checker, which has surpassed 10 million monthly users, is continuously developed and supervised by over 50 medical experts globally [ubiehealth.com/company/blog/AI-symptom-checker-surpasses-10-million-users][ubiehealth.com/doctors]. These experts include professionals from institutions like Oak Street Health, Texas Neuro Eye & Plastic Surgery, Beth Israel Deaconess Medical Center, Teladoc Health Services, and Northwell Health, ensuring the accuracy and reliability of its medical AI [ubiehealth.com/doctors]. The company's AI also leverages insights from over 900 medical institutions worldwide, constantly refining its algorithms with real-world clinical practice and data from over 50,000 publications from authoritative medical associations and journals [ubiehealth.com/clinical-data-sources][ubiehealth.com/how-ubies-ai-works][ubiehealth.com/].

Events

Ubie Event Participations

Ubie is actively involved in the healthcare ecosystem through strategic collaborations and partnerships, although direct event participation like hosting or sponsoring conferences is not extensively detailed. A significant highlight is Ubie's collaboration with Mayo Clinic to co-develop an AI-powered chat and voice platform. This initiative, announced in February 2026, aims to streamline healthcare access and enhance the patient experience through the Mayo Clinic Platform Accelerate program, indicating Ubie's engagement with leading medical institutions in innovative projects [https://ubiehealth.com/smart-support].

Beyond this major partnership, Ubie emphasizes collaboration with experienced doctors and medical institutions globally to continuously improve its AI-powered symptom checker [https://ubiehealth.com/]. The company's "Doctors who Develop Ubie" page showcases a diverse team of over 50 medical professionals from various specialties and locations, underlining Ubie's commitment to clinical rigor and expert involvement in its product development [https://ubiehealth.com/doctors]. These collaborations reflect Ubie's strategy of engaging with the medical community rather than solely through public events.

While specific event attendance or sponsorship details are not prominently featured, Ubie's business model naturally positions it within the digital health and AI in healthcare sectors. The company's Privacy Policy mentions that user data may be collected when individuals "register for and/or attend events organized by us" [https://ubiehealth.com/privacy-policy], suggesting that Ubie does indeed organize or participate in events, even if these are not extensively publicized on their main corporate pages. This indicates a potential for internal or industry-specific gatherings, further integrating Ubie into the broader healthcare dialogue.

Frequently Asked Questions

What does Ubie's recent extended Series C funding suggest about its strategic priorities?

Ubie's $45 million extended Series C funding, contributing to a cumulative total over $125 million, signals a strong focus on global expansion, particularly in the US market, and continued investment in its core generative AI and provider solutions. The backing by investors like Google and IDEO's Design for Ventures underscores confidence in this strategic direction.

What is the implication of Ubie's collaboration with Mayo Clinic on its product roadmap?

Ubie's collaboration with Mayo Clinic to co-develop an AI-powered chat and voice platform, Smart Support, indicates a strategic shift towards deeply integrated enterprise solutions for healthcare providers. This initiative, announced in February 2026, focuses on automating clinical intake, patient routing, and scheduling to streamline healthcare access and patient experience, signifying a roadmap emphasizing B2B offerings alongside its direct-to-consumer symptom checker.

How does Ubie's hiring structure reflect its global expansion strategy?

Ubie's hiring structure, with 240 employees in Tokyo, 10 in APAC, and 4 in the U.S., reflects a phased global expansion strategy, with a strong foundation in Japan and growing presence in key international markets. While full-time roles are currently filled, advising candidates to monitor LinkedIn for openings, this indicates a measured but continuous effort to build out its global team to support its AI-powered healthcare solutions.

What does Ubie's emphasis on medical professional involvement mean for its product development and competitive positioning?

Ubie's emphasis on developing and supervising its AI with over 50 medical professionals globally, including experts from institutions like Oak Street Health and Northwell Health, underscores its commitment to clinical rigor and accuracy. This extensive medical oversight enhances the reliability and trustworthiness of its AI Symptom Checker, strengthening its competitive position against other AI health platforms by ensuring medically validated solutions.

What differentiates Ubie's core offering from competitors like Infermedica and Healthline?

Ubie's core offering, a free, AI-powered symptom checker, differentiates itself through its user-friendly, 3-minute questionnaire that provides personalized reports on potential causes, treatment information, and guidance on when to seek professional medical attention. While Infermedica also offers an AI symptom checker, Ubie emphasizes its direct-to-consumer accessibility. Healthline, conversely, is primarily an information resource, lacking Ubie's interactive AI assessment tool.

Is Ubie's financial trajectory a turnaround or a warning sign?

Ubie's financial trajectory appears to be a growth phase, not a warning sign. With over $125 million in total funding, including a recent $45 million extended Series C, and recognition as one of Japan's fastest-growing startups by LinkedIn in 2021, the company demonstrates strong investor confidence. This capital supports global expansion and development of its AI platform for both consumers and over 1,800 healthcare organizations.

What implications does Ubie's product and pricing model have for market penetration?

Ubie's product and pricing model, offering a free AI symptom checker for individuals and a customized pricing model for its Smart Support platform for healthcare providers, enables broad market penetration. The free consumer tool attracts a large user base, exceeding 10 million monthly users, while the enterprise solution targets healthcare systems, allowing Ubie to capture both ends of the market without explicit pricing for the B2B solution.

How does Ubie's integration strategy for Smart Support affect its appeal to large health systems?

Ubie's Smart Support integration strategy, featuring bidirectional scheduling API support for EPIC and compatibility with Oracle Health and Athena systems, significantly enhances its appeal to large health systems. This broad compatibility allows for rapid implementation in as little as 90 days, avoiding disruptive 'rip-and-replace' processes, making it an attractive, low-friction solution for streamlining clinical intake and patient management.

What does Ubie's 'Doctors who Develop Ubie' page signify about its approach to AI validation?

Ubie's 'Doctors who Develop Ubie' page, showcasing over 50 medical professionals from various specialties and locations, signifies a rigorous, expert-led approach to AI validation. This commitment to clinical rigor ensures continuous improvement and expert review of its AI-powered symptom checker, enhancing the accuracy and trustworthiness of its medical AI through direct involvement of practicing physicians.

What is Ubie's strategic posture regarding direct event participation versus strategic collaborations?

Ubie's strategic posture emphasizes direct strategic collaborations and partnerships, such as its co-development with Mayo Clinic, over extensive public event participation. While its privacy policy suggests some internal or industry-specific events, the company's focus on engaging with leading medical institutions and a global network of doctors for product development reflects a strategy of embedding itself within the medical community for validation and growth.

Powered by ForesightIQ · Competitive intelligence from digital exhaust